CorMedix

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CorMedix and other ETFs, options, and stocks.

About CRMD

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. 

CEO
Joseph Todisco
CEOJoseph Todisco
Employees
191
Employees191
Headquarters
Berkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded
2006
Founded2006
Employees
191
Employees191

CRMD Key Statistics

Market cap
621.54M
Market cap621.54M
Price-Earnings ratio
3.69
Price-Earnings ratio3.69
Dividend yield
Dividend yield
Average volume
1.34M
Average volume1.34M
High today
$9.15
High today$9.15
Low today
$7.56
Low today$7.56
Open price
$8.58
Open price$8.58
Volume
4.32M
Volume4.32M
52 Week high
$17.43
52 Week high$17.43
52 Week low
$6.13
52 Week low$6.13

Stock Snapshot

With a market cap of 621.54M, CorMedix(CRMD) trades at $7.94. The stock has a price-to-earnings ratio of 3.69.

As of 2026-05-14, CorMedix(CRMD) stock has fluctuated between $7.56 and $9.15. The current price stands at $7.94, placing the stock +5.0% above today's low and -13.2% off the high.

CorMedix(CRMD) shares are trading with a volume of 4.32M, against a daily average of 1.34M.

During the past year, CorMedix(CRMD) stock moved between $6.13 at its lowest and $17.43 at its peak.

During the past year, CorMedix(CRMD) stock moved between $6.13 at its lowest and $17.43 at its peak.

CRMD News

TipRanks 1h
Cormedix Earnings Call Highlights Growth, Raises Outlook

Cormedix Inc. ((CRMD)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock hedge fund-level data and power...

The Motley Fool 7h
CorMedix Q1 2026 Earnings Transcript

Image source: The Motley Fool. Thursday, May 14, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — Joseph Todisco Executive Vice Pr...

CorMedix Q1 2026 Earnings Transcript
Benzinga 8h
CorMedix Stock Jumps As DefenCath Fuels Q1 Beat, 2026 Outlook Raised

• Cormedix stock is surging to new heights today. Why is CRMD stock up today? The company posted first-quarter net revenue of $127.4 million, up sharply from $3...

CorMedix Stock Jumps As DefenCath Fuels Q1 Beat, 2026 Outlook Raised

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

More CRMD News

TipRanks 14h
CorMedix reports Q1 EPS 43c, consensus 33c

Reports Q1 revenue $127.43M, consensus $104.96M. Joseph Todisco, CorMedix (CRMD) chairman and CEO, commented, “CorMedix has entered 2026 with strong momentum ac...

People also own

Based on the portfolios of people who own CRMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.